Roaring 2020’s Stock Market Rolls On Into ‘26 | WAYT?

By The Compound

Share:

Here's a comprehensive summary of the YouTube video transcript:

Key Concepts

  • Roaring 2020s: A period of economic and market expansion, drawing parallels to the 1920s, driven by technological advancements and resilient economic factors.
  • Bond Vigilantes: Investors who sell bonds to protest government deficits and inflation, potentially driving up interest rates.
  • Digital Revolution & AI: The ongoing evolution of technology, with AI being a key application impacting various sectors.
  • Baby Boomer Spending: The significant wealth and spending power of the retiring baby boomer generation contributing to economic resilience.
  • Mag 7 (Magnificent Seven): A group of large-cap technology stocks that have driven market performance.
  • ASICs (Application-Specific Integrated Circuits): Specialized chips designed for specific tasks, contrasted with more versatile GPUs.
  • GLP-1 Drugs: A class of drugs, particularly for diabetes and weight loss, driving significant growth in the pharmaceutical sector.
  • ARR (Annual Recurring Revenue): A business model where revenue is predictable and recurring, often seen in software and subscription services.

"Roaring 2020s" Economic and Market Outlook

The discussion centers on the optimistic outlook for the economy and stock market, drawing parallels to the "Roaring Twenties" of the 20th century. This perspective is championed by guest Ed Yardeni, who has consistently predicted a period of strong growth.

Key Points:

  • S&P 500 Earnings Projections: Yardeni forecasts S&P 500 operating earnings to rise from $268 per share in the current year to $310 next year, $350 in 2027, $400 in 2028, and $450 in 2029. This projection is based on an extrapolation of historical earnings growth rates (6-8%) and assumes profit margins will rise to record highs due to faster productivity growth.
  • S&P 500 Target: The base case scenario suggests the S&P 500 could reach 10,000 by the end of 2029, with potential to reach $500 per share in earnings by 2030. This target is derived by multiplying projected earnings by a Price-to-Earnings (P/E) ratio of 20.
  • P/E Ratio Range: The forward P/E for the S&P 500 is expected to range between 18 and 22 for the remainder of the decade, a shift from historical norms.
  • Historical Precedent: Yardeni highlights that a 200% gain over a decade, as projected for the S&P 500 from 2019 to 2029, has been exceeded in three of the previous decades since the 1920s.
  • Economic Resilience Factors:
    • Restructured Banking System: Post-2008 financial crisis reforms created shock absorbers in credit markets, preventing systemic credit crunches.
    • Federal Reserve's Role: The Fed is adept at managing financial markets and providing liquidity, effectively implementing a "Fed put."
    • Baby Boomer Spending: The wealthiest retiring generation, with $80 trillion in net worth, is actively spending, not deterred by higher interest rates, and their net worth continues to grow with the stock market. They are also supporting younger adult children and grandchildren.
    • Digital Revolution & AI: AI is seen as a transformative application with broad applicability across businesses and personal lives, just beginning to realize its potential. Cloud computing allows for flexible and cost-effective access to technology.
    • Federal Deficit: While acknowledging the large federal deficit, the sentiment is that it's not an immediate concern for the bond market, as evidenced by the current calm in bond yields.

Key Arguments & Perspectives:

  • Yardeni's Optimism: Ed Yardeni presents a consistently optimistic view, drawing parallels between the current technological boom and the 1920s, but believing the current decade will not end badly, potentially leading into "roaring 2030s."
  • Market Humility: Michael Batnick emphasizes the need for humility in the face of market volatility, citing the recent S&P 500 reversal after a strong earnings day as an example of the market's unpredictability.
  • Consumer Diversity: The understanding of consumer behavior needs to account for different segments, particularly the wealthy baby boomers, whose spending patterns are not always captured in standard economic analysis.

Notable Statements:

  • Ed Yardeni: "I'm talking about 10,000 on the S&P 500 by the end of 2029."
  • Ed Yardeni: "I think I'll be talking about the roaring 2030s."
  • Michael Batnick: "If you're not humbled by this market, you're a psycho."

The "Bond Vigilantes" and Deficit Concerns

The concept of "bond vigilantes" and the implications of the federal deficit are discussed.

Key Points:

  • Origin of the Term: Ed Yardeni coined the term "bond vigilantes" in July 1983.
  • Historical Context: In 1983, concerns were about $250 billion in annual deficits, a stark contrast to the current $1.5 to $2 trillion deficits.
  • Current Market Sentiment: Despite the large deficits, bond yields are currently calm, suggesting bond vigilantes are not actively protesting. Steve Eisman echoes this sentiment, noting that concerns about deficits have been ongoing for 35 years without significantly impacting investment decisions.

Key Argument: The immediate threat from bond vigilantes is perceived as low, allowing for continued investment despite large deficits.

The AI Arms Race and Market Dispersion

The conversation shifts to the competitive landscape of Artificial Intelligence (AI) and its impact on major technology companies, particularly the Magnificent Seven (Mag 7).

Key Points:

  • OpenAI's Impact: Sam Altman's actions at OpenAI are seen as a catalyst that has introduced "wall of worry" and led to market dispersion within the Mag 7.
  • Supplier Stress: Major suppliers to OpenAI, including SoftBank, Microsoft, AMD, and Oracle, have seen their stock prices react to the developments.
  • Alphabet vs. Nvidia:
    • Alphabet's Rise: Google (Alphabet) has experienced a significant rally, with its stock price on track for its best year since 2009. This is attributed to its advancements in AI, particularly its in-house development of AI models (Gemini 3) using its own hardware (TPUs).
    • Nvidia's Performance: While Nvidia has also performed well, its year-to-date gains are lower than Alphabet's.
    • Valuation Divergence: For the first time since 2016, Google is trading at a premium P/E ratio to Nvidia, a significant shift from historical trends where Nvidia was consistently more expensive.
    • Nvidia's Response: Nvidia has publicly responded to claims of obsolescence and accounting concerns, emphasizing its technological lead and the economic soundness of its business. They highlighted the longevity of their GPUs and their role in supplying Google.
  • Mag 7 Correlation Breakdown: A chart shows that prior to recent events, the Mag 7 stocks moved in unison. Now, they are being treated differently, reflecting individual company performance and narratives.
  • Narrative Driving Price: The belief is that in the case of Google and Nvidia, the narrative surrounding AI capabilities is driving price action, which in turn reinforces the narrative.

Key Arguments & Perspectives:

  • AI as a "Game of Thrones": The AI landscape is described as a competitive battleground with shifting alliances and fortunes among major tech players.
  • Buy-Side Skepticism: The stock price performance of companies partnering with OpenAI suggests that the buy-side is skeptical about the long-term earnings potential of these deals.
  • Nvidia's Defense: Nvidia's response to short-seller allegations, including comparisons to historical accounting frauds, is seen as a defensive move to protect its stock price and narrative.
  • ASICs vs. GPUs: The distinction between specialized ASICs and versatile GPUs is highlighted, with Nvidia asserting its dominance in the GPU market.

Notable Statements:

  • "The kingdom of Alphabet is currently rising."
  • Nvidia Newsroom Tweet: "NVIDIA is a generation ahead of the industry. It's the only platform that runs every AI model and does it everywhere computing is done."

MicroStrategy and Digital Asset Treasury Strategies

The discussion delves into MicroStrategy (now Strategy) and its unique business model of accumulating Bitcoin, and the broader implications for digital asset treasury strategies.

Key Points:

  • MicroStrategy's Business Model: The company has transformed into a Bitcoin accumulator, raising significant equity and debt capital to acquire the digital asset.
  • Stock Performance: MicroStrategy's stock has experienced a significant decline from its highs, down approximately 50% in three months and 65% from its mid-July peak.
  • Hedging Pressure: Tom Lee suggests that MicroStrategy's stock is under pressure because it serves as a convenient hedging tool for large Bitcoin holders. The liquidity of its options chain allows investors to short MicroStrategy or buy puts to hedge their Bitcoin long positions, as crypto derivatives offer limited hedging capacity.
  • Chicken and Egg Scenario: The question is raised whether Bitcoin is falling because MicroStrategy is selling, or if MicroStrategy is selling because its equity is declining.
  • Valuation Discount: MicroStrategy is now trading at a discount to the value of its underlying Bitcoin holdings, a reversal from its previous premium.
  • Enterprise Value Considerations: The discount to Net Asset Value (NAV) doesn't fully account for the company's preferred stock and traditional debt, which represent future obligations and interest payments.
  • FOMO and Time as a Cure: The tendency to experience Fear Of Missing Out (FOMO) on high-flying stocks like MicroStrategy is discussed. The "cure" for FOMO is often time, allowing for a more rational assessment of investments.
  • MSCI Index Exclusion Risk: JP Morgan highlights the risk of MicroStrategy being excluded from major equity indices by MSCI, which could lead to significant outflows from passive index funds.
  • "Strategy" vs. "MicroStrategy": The company's rebranding to "Strategy" is noted, and JP Morgan's continued use of "MicroStrategy" in their analysis is seen as a subtle jab.

Key Arguments & Perspectives:

  • MicroStrategy as a Leading Indicator: Tom Lee posits that MicroStrategy's stock performance acts as a leading indicator for the broader crypto market due to its role in hedging.
  • Not a Zero: Despite the decline, the sentiment is that MicroStrategy is not a zero and that Michael Saylor is unlikely to be forced to liquidate his Bitcoin holdings due to margin calls.
  • The Desire for Performance: The appeal of assets like MicroStrategy is often driven by the desire for performance rather than the asset itself. When performance falters, interest wanes.

Notable Statements:

  • Tom Lee: "Micro Strategy is essentially absorbing all the hedging pressure that the crypto industry is trying to do to protect their Bitcoin longs."
  • Josh Brown: "The cure for FOMO is time."

Equity Drawdowns: Recessionary vs. Non-Recessionary

A PIMCO table is presented to differentiate between recessionary and non-recessionary equity drawdowns, emphasizing the impact of recessions on market downturns.

Key Points:

  • Non-Recessionary Drawdowns: On average, these drawdowns are 17%, last five months, and do not typically involve a sustained recession.
  • Recessionary Drawdowns: These are more severe, averaging a 27% decline and lasting 11 months. They are characterized by significant pain and can lead to long-term investor skepticism.
  • Absence of Sustained Recession: The lack of a sustained recession over the past 16 years is cited as a primary reason for the absence of a prolonged 40% bear market.
  • Frequent 20% Drawdowns: While 40% bear markets are rare without a recession, there have been numerous 19% (or approximately 20%) drawdowns in recent years, indicating frequent, shorter-term market pullbacks.

Key Argument: The distinction between recessionary and non-recessionary drawdowns is crucial for investors to understand the potential depth and duration of market downturns and to adjust their strategies accordingly.

Actionable Insight: Investors should differentiate between normal market pullbacks and recession-driven bear markets, as the latter have a significantly greater impact on portfolio value and investor psychology.

Healthcare Sector Strength and Pharmaceutical Innovation

The healthcare sector, particularly pharmaceutical companies, is highlighted as a strong area of investment, driven by innovation and significant growth in specific drug categories.

Key Points:

  • Eli Lilly's Trillion-Dollar Milestone: Eli Lilly has become the first healthcare stock to reach a $1 trillion market capitalization, joining an elite group of companies.
  • GLP-1 Drug Success: Lilly's weight loss and diabetes drugs (Zepbound and Mounjaro) have generated $19 billion in sales in the first nine months of the year, surpassing the sales of Merck's blockbuster cancer immunotherapy, Keytruda.
  • Future Sales Projections: Analysts project $100 billion in annual sales for these GLP-1 drugs by 2030.
  • Relative Valuation: At a trillion dollars, Lilly is twice the size of its closest competitor, Johnson & Johnson, and worth more than Walmart.
  • Turnaround Story: Eli Lilly is presented as a remarkable turnaround story, having been considered a struggling company a decade ago before finding success in the metabolic market.
  • Measurement and Instruments Sector: Companies like Metler Toledo, Thermo Fisher Scientific, and Agilent are identified as strong performers within the broader healthcare ecosystem, benefiting from a shift towards Annual Recurring Revenue (ARR) models.
  • ARR Business Model Transformation: These companies are transitioning from traditional sales models to subscription-based revenue streams, making them more predictable and attractive to investors.

Key Arguments & Perspectives:

  • Healthcare as a Growth Engine: The innovation in pharmaceuticals, particularly in areas like GLP-1 drugs, is driving significant growth and making healthcare a leading sector.
  • Long-Term Potential: The success of companies like Eli Lilly suggests substantial upside potential for other players in the pharmaceutical and medical instrument sectors.
  • Transformation of Business Models: The shift to ARR models is a key factor in the improved performance and investor sentiment towards companies in the measurement and instruments sector.

Notable Statements:

  • "Eli Lilly is now bigger than Keytruda, which is Merck's flagship cancer immunotherapy."
  • "These are ARR businesses now... they start to look more like software companies."

Mystery Chart: A Left-Behind Stock with Strong Fundamentals

A "mystery chart" is presented, highlighting a stock that has been overlooked but is showing strong fundamental performance.

Key Points:

  • Stock Identification: The stock is identified as one that Josh Brown had previously made a compelling case for.
  • Underlying Fundamentals: The company exceeded revenue growth forecasts (4.5% vs. 3% expected), with improvements in gross margins and strong growth in its enterprise business segment (companies spending over $100,000).
  • AI Product Growth: A significant increase (4x) in their AI companion product is noted.
  • Positive Outlook: The presenter expresses confidence in the stock's future performance, believing it can reach $100.

Key Argument: Strong, often overlooked, fundamental performance can lead to significant stock price appreciation, especially when expectations are low.

Actionable Insight: Investors should look for companies with solid underlying fundamentals that are not yet widely recognized by the market.

Conclusion and Thanksgiving Wishes

The hosts conclude the show by thanking their guests and viewers, wishing everyone a Happy Thanksgiving, and previewing the next episode.

Key Takeaways:

  • The market remains dynamic and unpredictable, requiring humility and adaptability.
  • Optimistic long-term outlooks, like the "Roaring 2020s" thesis, are supported by technological advancements and resilient economic factors.
  • The AI landscape is highly competitive, leading to significant dispersion in stock performance among tech giants.
  • Innovation in sectors like healthcare, particularly pharmaceuticals, presents compelling investment opportunities.
  • Underlying business fundamentals and evolving business models are crucial drivers of stock performance.
  • The market never truly "ends," offering continuous opportunities and challenges for investors.

Chat with this Video

AI-Powered

Hi! I can answer questions about this video "Roaring 2020’s Stock Market Rolls On Into ‘26 | WAYT?". What would you like to know?

Chat is based on the transcript of this video and may not be 100% accurate.

Related Videos

Ready to summarize another video?

Summarize YouTube Video